A research team at Monash University has cured a formerly fatal disease.
The road to finding a cure began in 2009 when Monash Health cured ‘Baby Z’, the first baby to survive molybdenum cofactor deficiency Type-A. Previously, babies born with the disease did not survive past infancy. The condition occurs in newborns and causes toxic sulphites to rapidly accumulate, leading to seizures and the death of brain tissue.
A team of neonatologists, led by Dr Alex Veldman, identified a possible treatment that had never been used in humans. The treatment was successful, making Baby Z to become the first human to survive the condition.
Now, the treatment has been validated by research published in The Lancet, a prestigious journal.